http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0105353-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-16
filingDate 2000-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f913bdcf0212472ed5418773432f2f66
publicationDate 2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0105353-A2
titleOfInvention Heterocyclic intermediates useful in the preparation of (5R) - (Methylamino) -5,6-dihydro-4H-imidazo [4,5,1-ij] quinolin-2 (1H) -one
abstract The present invention relates to a process for the preparation of a pharmaceutically acceptable (5R) - (methylamino) -5,6-dihydro-4H-imidazo [4,5,1-ij] quinolin-2 (1H) -one, i.e. a compound of formula (VII). recyclable intermediates. Typical of these are the compounds of formula (II): wherein RN is benzyl (A), the phenyl moiety of which is optionally substituted by one or two independently selected fluorine, chlorine, bromine or iodine atoms or alkyl or alkoxy; (B) RN1-CH2-O-CH2-, wherein RN1 is (1) phenyl optionally substituted with fluorine, chlorine, bromine or iodine or alkyl or alkoxy, (2) (CH3) 3Si-CH2- ; (3) RN2-O-CH2, wherein RN2 is alkyl, (4) CH2 = CH-, (5) hydrogen, (6) alkyl; (C) unsaturated CH2 = CH-CH2-, CH3-CH = CH-CH2- or phenyl-CH = CH-CH2-. SHE
priorityDate 1999-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834

Total number of triples: 30.